MeSH Browser

MeSH Supplementary: casirivimab and imdevimab drug combination
Unique ID: C000711751
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000711751
Entry Term(s): REGEN-COV; REGN-COV; REGN-COV-2; REGN-COV2; REGN10987 and REGN10933 mixture; Ronapreve; Ronpreve; casirivimab and imdevimab; casirivimab plus imdevimab; casirivimab, imdevimab drug combination; casirivimab-imdevimab
Pharm Action: Antiviral Agents
Registry Numbers: 0
Heading Mapped to: Drug Combinations; *Antibodies, Neutralizing; *Antibodies, Monoclonal, Humanized
Frequency: 56
Note: a mixture of anti-SARS-Cov-2 antibodies
Date of Entry: 2020/12/14
Revision Date: 2022/01/26

Concept UI: M000741836
Registry Numbers: 0
Terms: REGN-COV-2 Preferred Term
Term UI T001093259
Date12/14/2020
LexicalTag LAB
ThesaurusID NLM (2021); REGN-COV
Term UI T001105933
Date05/05/2021
LexicalTag NON
ThesaurusID NLM (2021); REGN10987 and REGN10933 mixture
Term UI T001093260
Date12/14/2020
LexicalTag NON
ThesaurusID NLM (2021); REGN-COV2
Term UI T001094530
Date01/08/2021
LexicalTag NON
ThesaurusID NLM (2021)

casirivimab and imdevimab drug combination MeSH Supplementary Concept Data 2025